Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
48 /100
MEDIUM RISK
Score updated Oct 13, 2026

FBIO — Fortress Biotech, Inc. Dilution Risk Tracker

Track FBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FBIO — Get alerts when the score changes →

As of October 13, 2026, Fortress Biotech, Inc. (FBIO) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Fortress Biotech, Inc. has a market capitalization of $174.02M, 82.47M shares outstanding, 22 institutional holders tracked. Stored dilution-related fields include 12.74M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰Cash Runway—
📊 Float Risk
85
⚠️ Warrant Exposure
50
🔄 Convertible Debt
35

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
📜 Warrant Exercise model 25%
• Significant warrants: 15% of shares outstanding
🔁 Convertible Conversion model 15%
• Convertible debt present: 8.6% potential dilution
🔔 Track FBIO — Get forecast alerts →

Market Data

Market Cap$174.02M
Shares Outstanding82.47M
Float22.38M
Cash$196.58M
Debt$398.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore48/100DilutionWatch score record
Shares Outstanding82.47MVerified float table or market cache
Public Float22.38MVerified float table or market cache
Market Cap$174.02MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants12.74MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

22 institutional holders · 534.2K shares
#1 Kestra Advisory Services, LLC 176.0K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 92.8K shares
#3 BlackRock, Inc. 84.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.90M
Days to Cover18.4
% of Float21.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2022-03-28
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual FBIO Dilution Snapshot

Fortress Biotech, Inc. (FBIO) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

FBIO's DilutionScore is currently 48/100 (Medium risk), with 4 score changes tracked over 89 days. The score deteriorated from 52/100 (High risk).

Period Score Risk Level Duration
Oct 11 – Oct 13, 202648/100MEDIUM3 days
Sep 28 – Oct 10, 202652/100HIGH13 days
Aug 22 – Sep 27, 202651/100HIGH37 days
Aug 14 – Aug 21, 202646/100MEDIUM7 days
Jul 16 – Aug 13, 202651/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

FBIO shares outstanding have increased 7.0% from 31.04M (Mar 2026) to 33.22M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 09, 202633.22M22.38M▲ 1.40%
May 03, 202633.22M22.07M▼ 0.32%
Apr 13, 202632.20M22.15M▼ 0.01%
Apr 09, 202632.20M22.15M▲ 1.73%
Apr 03, 202631.36M21.77M▲ 3.75%
Mar 23, 202631.04M20.98M▼ 10.53%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track FBIO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment FBIO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking FBIO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for FBIO
FBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.